Regression of deep vein thrombosis by I.V.-administration of a low molecular weight heparin-results of a pilot study-

This publication has 17 references indexed in Scilit:

• Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
  New England Journal of Medicine, 1992
• Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
  The Lancet, 1992
• A Randomised Trial of Subcutaneous Low Molecular Weight Heparin (CY 216) Compared with lntravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis
  Thrombosis and Haemostasis, 1991
• Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
  British Journal of Surgery, 1988
• A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery
  Thrombosis and Haemostasis, 1988
• Studies on the Profibrinolytic Actions of Heparin and Its Fractions
  Seminars in Thrombosis and Hemostasis, 1985
• Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.
  BMJ, 1982
• Heparin therapy in venous thromboembolism
  The American Journal of Medicine, 1981
• HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPY
  The Lancet, 1977
• Management of Heparin Therapy
  New England Journal of Medicine, 1975